Technology News and Research

RSS

Aperio Technologies forges alliance with HistoRx to provide an integrated whole-slide imaging system

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, and HistoRx, Inc., (HistoRx), a leader in the emerging field of tissue-based assays for targeted patient treatment, have entered into a partnership to provide an integrated solution for whole-slide imaging with fluorescence.

10 Sep 2009

MedVentive’s POC platform implemented at Hartford PHO

We are pleased to announce that Hartford PHO has gone live using MedVentive’s advanced clinical registries and sophisticated point of care (POC) decision support platform to help them improve the quality and coordination of patient care, promote efficiency, and support their clinical integration program.

10 Sep 2009

ARUP Laboratories' scientist receives grant to research HIV therapies

ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced that ARUP's Tanya Sandrock, PhD, Research & Development scientist, received a prestigious National Institutes of Health (NIH) grant to research additional HIV therapies.

9 Sep 2009

North Carolina Biotechnology Center awarded a transformational grant by the Biogen Idec Foundation

The Biogen Idec Foundation today announced it has awarded a $1 million Transformational Grant in Science Education to the North Carolina Biotechnology Center to support the expansion of the Center’s educational training facility for K-12 science teachers. The grant is part of the Biogen Idec Foundation’s new Transformational Grants in Science Education initiative. The Foundation has awarded approximately $1.5 million in transformational grants since the program was initiated in 2008.

9 Sep 2009

American International Pathology Laboratories provides jobs to Walter Reed AFIP pathologists

American International Pathology Laboratories (AIPL), a division of Bostwick Laboratories, opens its doors today, providing positions to more than 40 civilian pathologists and staff formerly of the Armed Forces Institute of Pathology at Walter Reed Army Medical Center. The 150-year-old Institute will cease operations when Walter Reed closes under the Federal Base Realignment and Closure program.

9 Sep 2009

New electronic credentialing system for managed care organizations

OneBeacon Professional Partners, a member of OneBeacon Insurance Group (NYSE: OB), today announced an alliance with Medversant Technologies, LLC to offer OneBeacon managed care customers AutoVerifi(TM), a patented, electronic credentialing verification and management system that continuously validates, stores and retrieves records of medical providers.

9 Sep 2009

Cepheid's Flu Panel test to provide 45-minute identification of Flu A infection

Cepheid (Nasdaq: CPHD) today announced the accelerated development of a Flu A (Influenza Virus) Panel test for use on the GeneXpert((R)) System. The test will be designed to provide 45-minute identification of Flu A infection, with specific presumptive identification of seasonal H1, seasonal H3, and H1N1 novel strain types.

9 Sep 2009

Fourth-quarter and full year fiscal 2009 results announced by Rural/Metro

Rural/Metro Corporation (NASDAQ: RURL), a leading provider of ambulance and private fire protection services, announced results today for its fiscal 2009 fourth quarter and full year, highlighting strong cash-flow generation, growth in profitability, and further progress in reducing uncompensated care.

9 Sep 2009

WRAIR to test Kane Biotech's DispersinB biofilm technology against pathogens in combat trauma wounds

Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that the Company has entered into a Cooperative Research and Development Agreement for Material Transfer (CRADA-MT) with the Walter Reed Army Institute of Research (WRAIR) in Silver Springs, Maryland.

9 Sep 2009

Silverlink’s Medicare communications solutions to help health plans tackle forthcoming changes in healthcare

Silverlink Communications® Inc., the leader in healthcare consumer communications, today announced solutions focused specifically on the Medicare market. These services help health plans more effectively communicate with beneficiaries, especially important in the 2010 plan year open enrollment season starting in October 2009.

9 Sep 2009

Medpro completes preliminary testing and regulatory requirements for its VACUETTE safety needle system

MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development and marketing of passive needlestick injury prevention technology, announced today it has completed preliminary testing and regulatory requirements for the VACUETTE® PREMIUM Safety Needle System Tube-Touch model, a single-patient, multiple sample blood collection safety needle system.

9 Sep 2009

Ceragenix awarded $2.87M NIH grant to develop a drug for treating Clostrdium difficile and Shigella

Ceragenix Pharmaceuticals, Inc. (“Ceragenix”) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health (“NIH”) has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.

9 Sep 2009

GENova Biotherapeutics discusses its anti-cancer drug development strategy

GENova Biotherapeutics, Inc., ("GENova"), today released important information about its anti-cancer drug development strategy and its unique niche in the drug development industry.

9 Sep 2009

Neuralstem's patent on neural stem cell transplantation approved

Neuralstem, Inc. today announced that it has received notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent entitled “Transplantation of Human Neural Cells For Treatment Of Neurodegenerative Conditions,” number 11/281,640.

9 Sep 2009

U.S. Navy and Solazyme to develop algae-derived advanced biofuel

Solazyme, Inc., the renewable oil production company and leader in algal synthetic biology, has been selected by the U.S. Department of Defense (DoD) to research, develop, and demonstrate commercial scale production of algae-derived advanced biofuel that meets the United States Navy’s rigorous specifications for military tactical platforms.

9 Sep 2009

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

Sequoia Hospital announced that the Cardiac Arrhythmia Program has completed 1,000 atrial fibrillation (A-Fib) ablation procedures, making it the highest total volume A-Fib ablation institution currently performing ablations in Northern and Central California.

9 Sep 2009

International Institute of Biomedical Sciences and Technology established for a global research initiative

Upstate Medical University in Syracuse, New York, the Technion-Israel Institute of Technology in Haifa, Israel, and National Cheng Kung University in Tainan City, Taiwan, have announced the creation of the International Institute of Biomedical Sciences and Technology that will facilitate the collaboration of research across three continents and accelerate the development of novel bioengineering, diagnostic and biomedical products for the treatment and cure of disease, officials said today.

9 Sep 2009

TURis plasma vaporization electrode for benign prostatic hyperplasia therapy

The TURis plasma vaporization electrode does not cut off tissue with a loop, but energetically vaporizes the tissue with a small button electrode. With the help of the latest plasma technology, cells can be removed by merely gliding the electrode over the prostate tissue.

From Evident Corporation - Life Sciences 9 Sep 2009

Bayer submits an IND for its MN-IC antibody-drug conjugate to the FDA

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer’s submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.

9 Sep 2009

New web-based tool guide practices to become patient-centered medical home

The American College of Physicians (ACP) is offering a new, web-based tool to help guide practices through the process of becoming a patient-centered medical home (PCMH).

9 Sep 2009

Technology News and Research

Aperio Technologies forges alliance with HistoRx to provide an integrated whole-slide imaging system

MedVentive’s POC platform implemented at Hartford PHO

ARUP Laboratories' scientist receives grant to research HIV therapies

North Carolina Biotechnology Center awarded a transformational grant by the Biogen Idec Foundation

American International Pathology Laboratories provides jobs to Walter Reed AFIP pathologists

New electronic credentialing system for managed care organizations

Cepheid's Flu Panel test to provide 45-minute identification of Flu A infection

Fourth-quarter and full year fiscal 2009 results announced by Rural/Metro

WRAIR to test Kane Biotech's DispersinB biofilm technology against pathogens in combat trauma wounds

Silverlink’s Medicare communications solutions to help health plans tackle forthcoming changes in healthcare

Medpro completes preliminary testing and regulatory requirements for its VACUETTE safety needle system

Ceragenix awarded $2.87M NIH grant to develop a drug for treating Clostrdium difficile and Shigella

GENova Biotherapeutics discusses its anti-cancer drug development strategy

Neuralstem's patent on neural stem cell transplantation approved

U.S. Navy and Solazyme to develop algae-derived advanced biofuel

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

International Institute of Biomedical Sciences and Technology established for a global research initiative

TURis plasma vaporization electrode for benign prostatic hyperplasia therapy

Bayer submits an IND for its MN-IC antibody-drug conjugate to the FDA

New web-based tool guide practices to become patient-centered medical home

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News